Harnessing personalized tailored medicines to digital-based data-enriched edible pharmaceuticals.
digital dosage
drug delivery
pediatric
personalized medicine
quick response
Journal
Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
18
09
2022
revised:
26
02
2023
accepted:
09
03
2023
medline:
8
5
2023
pubmed:
18
3
2023
entrez:
17
3
2023
Statut:
ppublish
Résumé
Tailoring drug products to personalized medicines poses challenges for conventional dosage forms. The prominent reason is the restricted availability of flexible dosage strengths in the market. Inappropriate dosage strengths lead to adverse drug reactions or compromised therapeutic effects. The situation worsens when the drug has a narrow therapeutic window. To overcome these challenges, data-enriched edible pharmaceuticals (DEEP) are novel concepts for designing solid oral products. DEEP have individualized doses and information embedded in quick response (QR) code form. When data are presented in a QR code, the information is printed with edible ink that contains the drug in tailored doses required for the patients.
Identifiants
pubmed: 36931386
pii: S1359-6446(23)00071-5
doi: 10.1016/j.drudis.2023.103555
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Dosage Forms
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103555Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.